Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Repare Therapeutics (Nasdaq: RPTX), a leading clinical-stage precision oncology company, has announced its participation in two upcoming investor conferences in September 2024. The company's senior management team will be presenting at:
1. Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, at 1:05 p.m. ET in New York, NY, for a fireside chat.
2. H.C. Wainwright 26th Annual Global Investment Conference on September 11, 2024, at 9:00 a.m. ET in New York, NY, for a company overview.
Live webcasts of both presentations will be available on the company's website, with replays archived for at least 30 days.
Repare Therapeutics (Nasdaq: RPTX), un'azienda leader nella oncologia di precisione in fase clinica, ha annunciato la sua partecipazione a due conferenze per investitori in programma a settembre 2024. Il team di alta dirigenza dell'azienda presenterà:
1. 22ª Conferenza Annuale Global Healthcare di Morgan Stanley il 5 settembre 2024, alle 13:05 ET a New York, NY, per una conversazione informale.
2. 26ª Conferenza Annuale Globale sugli Investimenti di H.C. Wainwright l'11 settembre 2024, alle 9:00 ET a New York, NY, per una panoramica dell'azienda.
Le dirette web delle due presentazioni saranno disponibili sul sito web dell'azienda, con repliche archiviate per almeno 30 giorni.
Repare Therapeutics (Nasdaq: RPTX), una empresa líder en oncología de precisión en etapa clínica, ha anunciado su participación en dos conferencias para inversores que se llevarán a cabo en septiembre de 2024. El equipo de alta dirección de la empresa presentará:
1. 22ª Conferencia Anual Global de Salud de Morgan Stanley el 5 de septiembre de 2024, a la 1:05 p.m. ET en Nueva York, NY, para una charla informal.
2. 26ª Conferencia Anual Global de Inversión de H.C. Wainwright el 11 de septiembre de 2024, a las 9:00 a.m. ET en Nueva York, NY, para una visión general de la empresa.
Las transmisiones en vivo de ambas presentaciones estarán disponibles en el sitio web de la empresa, con repeticiones archivadas por al menos 30 días.
Repare Therapeutics (Nasdaq: RPTX)는 임상 단계의 정밀 온콜로지 회사로, 2024년 9월 예정된 두 개의 투자자 회의에 참여할 것이라고 발표했습니다. 회사의 고위 경영진 팀은 다음과 같이 발표할 것입니다:
1. 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스가 2024년 9월 5일 오후 1시 5분(ET) 뉴욕에서 비공식 대화로 열립니다.
2. H.C. 웨인라이트 제26회 연례 글로벌 투자 컨퍼런스가 2024년 9월 11일 오전 9시(ET) 뉴욕에서 회사 개요를 위해 진행됩니다.
두 발표 모두 회사 웹사이트에서 라이브 웹캐스트로 제공되며, 적어도 30일 동안 재생이 가능할 것입니다.
Repare Therapeutics (Nasdaq: RPTX), une entreprise de premier plan dans le domaine de l'oncologie de précision en phase clinique, a annoncé sa participation à deux conférences pour investisseurs à venir en septembre 2024. L'équipe de direction supérieure de l'entreprise présentera :
1. 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 5 septembre 2024 à 13h05 ET à New York, NY, pour une conversation informelle.
2. 26ème Conférence Annuelle Mondiale sur les Investissements de H.C. Wainwright le 11 septembre 2024 à 9h00 ET à New York, NY, pour une présentation de l'entreprise.
Des webdiffusions en direct des deux présentations seront disponibles sur le site web de l'entreprise, avec des rediffusions archivées pendant au moins 30 jours.
Repare Therapeutics (Nasdaq: RPTX), ein führendes Unternehmen im Bereich der präzisen Onkologie in der klinischen Phase, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben. Das leitende Management-Team des Unternehmens wird Folgendes präsentieren:
1. 22. Jährliche Global Healthcare Konferenz von Morgan Stanley am 5. September 2024 um 13:05 Uhr ET in New York, NY, für ein informelles Gespräch.
2. 26. Jährliche Globale Investorenkonferenz von H.C. Wainwright am 11. September 2024 um 9:00 Uhr ET in New York, NY, für eine Unternehmensübersicht.
Live-Webcasts beider Präsentationen werden auf der Unternehmenswebsite zur Verfügung stehen, mit Archivaufnahmen für mindestens 30 Tage.
- None.
- None.
Morgan Stanley 22nd Annual Global Healthcare Conference
Fireside Chat
Date: Thursday, September 5, 2024
Time: 1:05 p.m. Eastern Time
Location:
H.C. Wainwright 26th Annual Global Investment Conference
Company Overview
Date: Wednesday, September 11, 2024
Time: 9:00 a.m. Eastern Time
Location:
A live webcast of the presentations can be accessed in the Investor section of the Company’s website at https://ir.reparerx.com/news-and-events/events. A replay of the webcast will be archived on the Company’s website for at least 30 days.
About Repare Therapeutics, Inc.
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes lunresertib (also known as
SNIPRx® is a registered trademark of Repare Therapeutics Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240827041601/en/
Investor Relations & Media:
Robin Garner
Vice President and Head of Investor Relations
Repare Therapeutics Inc.
investor@reparerx.com
Source: Repare Therapeutics Inc.
FAQ
When is Repare Therapeutics (RPTX) presenting at the Morgan Stanley Global Healthcare Conference in 2024?
What type of presentation will Repare Therapeutics (RPTX) give at the H.C. Wainwright Global Investment Conference?
How can investors access the webcasts of Repare Therapeutics' (RPTX) conference presentations?
How long will the replays of Repare Therapeutics' (RPTX) conference presentations be available?
